Clindamycin USP: Brands, Price & Uses in Bangladesh

Serious Anaerobic and Susceptible Gram-Positive Bacterial Infections

Clindamycin USP is an established treatment, given orally or by injection, for serious infections caused by susceptible anaerobic bacteria and susceptible strains of streptococci, pneumococci, and staphylococci. Because of the risk of Clostridioides difficile-associated diarrhea (see Precautions and Warnings), Clindamycin USP is generally reserved for patients who are allergic to penicillin, or for infections in which a penicillin is inappropriate or clinically inferior, including:

• Lower respiratory tract infections, including anaerobic lung abscess, aspiration pneumonia, and empyema
• Serious skin and soft-tissue infections, including some necrotizing soft-tissue infections (often as part of combination therapy)
• Septicemia caused by susceptible staphylococci, streptococci, and anaerobes
• Intra-abdominal infections, including peritonitis and intra-abdominal abscess caused by susceptible anaerobes (typically combined with an agent active against gram-negative aerobes)
• Female pelvic and genital tract infections, such as endometritis, pelvic cellulitis, and pelvic inflammatory disease caused by susceptible anaerobes (guideline-supported regimens typically combine Clindamycin USP with another antibiotic, for example an aminoglycoside, to cover the full range of likely organisms)

Bone and Joint Infections

Clindamycin USP is an established adjunct to surgical treatment for chronic bone and joint infections caused by susceptible staphylococci.

Malaria (Off-Label, Guideline-Supported Combination Use)

Clindamycin USP is used off-label, always in combination with quinine, for the treatment of certain forms of malaria, including in pregnant women when other options are unsuitable; this is a guideline-recognized use but Clindamycin USP is never used alone for malaria.

Toxoplasmosis and Pneumocystis Infections (Off-Label, Alternative Regimens)

Clindamycin USP, generally combined with pyrimethamine, is used off-label as an alternative treatment for toxoplasmosis, including in patients who cannot tolerate sulfonamides. Clindamycin USP combined with primaquine is also used off-label as an alternative regimen for Pneumocystis jirovecii pneumonia in patients unable to take first-line therapy.

Bacterial Vaginosis

Topical (vaginal) formulations of Clindamycin USP are an established treatment for bacterial vaginosis.

Acne Vulgaris

Topical (skin) formulations of Clindamycin USP are an established adjunctive treatment for moderate to severe acne vulgaris, generally used as part of a broader skin-care regimen rather than as monotherapy, and typically for a limited, periodically reassessed course.

Endocarditis Prophylaxis (Guideline-Supported Alternative)

Clindamycin USP is a guideline-supported alternative for antibiotic prophylaxis against infective endocarditis in penicillin-allergic patients undergoing certain dental or invasive procedures, in patients at highest risk of adverse outcomes from endocarditis.

Important: Clindamycin USP is not indicated for the treatment of meningitis, as it does not penetrate the cerebrospinal fluid in adequate concentrations.

The dose, route, frequency, and duration of Clindamycin USP vary considerably by indication, severity of infection, patient age and weight, and organ function, and must be determined by a qualified healthcare professional; a regimen used for one infection or dosage form is not necessarily appropriate for another. Take Clindamycin USP exactly as prescribed by your physician; do not stop, extend, skip doses, or share Clindamycin USP with others without medical advice, and complete the full prescribed course even if symptoms improve early.

Common Side Effects

• Diarrhea, nausea, vomiting, and abdominal pain or cramping
• Metallic taste (with intravenous administration)
• Skin rash
• Local irritation, dryness, redness, or peeling with topical use
• Local burning, itching, or irritation with vaginal use
• Pain, induration, or abscess formation at intramuscular injection sites; thrombophlebitis with intravenous use

Serious Side Effects (Seek Medical Attention)

• Severe, persistent, or bloody diarrhea, which may indicate Clostridioides difficile-associated diarrhea or pseudomembranous colitis — see Precautions and Warnings for details
• Signs of a severe allergic reaction, such as swelling of the face/throat, difficulty breathing, or widespread hives (possible anaphylaxis)
• Severe skin reactions such as blistering, peeling skin, or widespread rash (possible Stevens-Johnson syndrome or toxic epidermal necrolysis)
• Yellowing of the skin or eyes, dark urine, or unusual tiredness, which may indicate liver injury
• Signs of a blood disorder, such as unusual bruising, bleeding, sore throat, or fever (rare reports of agranulocytosis)
• Reduced kidney function or worsening kidney function markers